SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-162738 | Pharmaceuticals and Healthcare
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Swine Reproductive and Respiratory Syndrome Vaccine Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET
7.1 GLOBAL SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 ASCENT CORPORATION
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Boehringer-Ingelheim
16.3 MSD Animal Health
16.4 SPAH
16.5 Ceva
16.6 Chengdu TECH-BANK Biological Products Co .Ltd
16.7 ringpu
16.8 QILU ANIMAL HEALTH PRODUCTS CO. LTD
16.9 DAHUANONG
16.10 CAVAC
16.11 Komipharm
16.12 Agrovet
16.13 Bioveta
16.14 JINYU BIO-TECNOLOGY CO. LTD
16.15 Phibro Animal Health
16.16 ANHUI TIANKANG(GROUP)SHRES O. LTD
16.17 Zoetis
16.18 WINSUN BIO
16.19 PULIKE BIOLOGICAL ENGINERING INC.
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By TypeActive Vaccine
Inactivated Vaccines
By Application
Government Tender
Market Sales
Companies
ASCENT CORPORATION
Boehringer-Ingelheim
MSD Animal Health
SPAH
Ceva
Chengdu TECH-BANK Biological Products Co .Ltd
ringpu
QILU ANIMAL HEALTH PRODUCTS CO. LTD
DAHUANONG
CAVAC
Komipharm
Agrovet
Bioveta
JINYU BIO-TECNOLOGY CO. LTD
Phibro Animal Health
ANHUI TIANKANG(GROUP)SHRES O. LTD
Zoetis
WINSUN BIO
PULIKE BIOLOGICAL ENGINERING INC.
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.